ARCHIVES

Trifluridine and Tipiracil Hydrochloride Increase OS, PFS in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Marijuana-Derived Drug Less Effective Than Standard

March 29, 2002

CHOP Training Conference Planned

January 23, 1981

Final NIH ethics rules retain consulting ban, but limit divesture requirement to senior employees.

September 9, 2005

DCPC Advisors Okay Omnibus Prevention Program Announcement

January 24, 1992

Urgent Need For New Drugs To Treat Pre-Cancers: AACR.

March 1, 2002

Trials Approved by NCI CTEP For the Month of March

March 30, 2012